My Special Cytosorb Case. Fabio Silvio TACCONE Dpt of Intensive Care Hôpital Erasme ULB Brussels (BE)

Similar documents
ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest

Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand

Printed copies of this document may not be up to date, obtain the most recent version from

Acute Liver Failure: Supporting Other Organs

Rounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

The heat is on (and on)

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Year in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

Staging Sepsis for the Emergency Department: Physician

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

Methamphetamine Abuse During Pregnancy

Printed copies of this document may not be up to date, obtain the most recent version from

Clinical Pathway: Management Of The Life-Threatening Overdose

Dancing with Death: MDMA, PMMA and other 4 letter words

Surviving Sepsis: A CRASH Course. Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

BREAK 11:10-11:

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

9/25/2017. Nothing to disclose

Nothing to disclose 9/25/2017

Update in Critical Care Medicine

Pulmonary Embolism Is it the Greatest Danger in Deep Vein Thrombosis?

Wanchai Wongkornrat Cardiovascular Thoracic Surgery Siriraj Hospital Mahidol University

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

Application of Lung Protective Ventilation MUST Begin Immediately After Intubation

John Park, MD Assistant Professor of Medicine

Indian Diploma in Critical Care Nursing

Case Scenario 3: Shock and Sepsis

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

DR J HARTY / DR CM RITCHIE / DR M GIBBONS

Michael Avant, M.D. The Children s Hospital of GHS

Welcome! While we wait, please open PollEv.com/jhhicu012

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018

Poisoning: from paracetamol to legal highs.

SHOCK Susanna Hilda Hutajulu, MD, PhD

Ralph Palumbo, MD, FCCP

STORMY DENGUE with bloody problems. Anand M.Patil PICU MED/SURG TEAM Apollo Childrens Hospitals Chennai

Case conference. Welcome Dr. Lawrence Tierney

Tables of Normal Values (As of February 2005)

Chapter 5: Sepsis Stephen Lo

Weaning and extubation in PICU An evidence-based approach

Prone ventilation revisited in H1N1 patients

Definition : Stages : ( RIFLE vs. AKIN ) Causes and classification : Pre-renal Renal Post- renal Clinical manifestations and Complication Management

Goals for sedation during mechanical ventilation

Sedation Hold/Interruption and Weaning Protocol ( Wake-up and Breathe )

Reverse (fluid) resuscitation Should we be doing it? NAHLA IRTIZA ISMAIL

ECMO for treatment of cardiotoxic intoxications

ECLS Registry Form Extracorporeal Life Support Organization (ELSO)

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

TREATMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY WITH COOLING Children s Hospital & Research Center Oakland Guideline Revised by P.

Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

LAS VEGAS Case Report Form 1 Intra-Operative

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

ICU management and referral guidelines for severe hypoxic respiratory failure

Resuscitation Fluids

Inflammation. Sepsis Ladder

99 Problems but hyperglycemia ain t one SHEEREENE HUSSAIN MD, MA RAPID CITY REGIONAL HOSPITAL HOSPITALIST DEPARTMENT SEPT 12, 2018

POST-OP CARDIAC SURGERY PHYSICIAN S ORDER SHEET USE BALLPOINT PEN ONLY. CARDIAC INTENSIVE CARE UNIT

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Critical Care Treatment Guidelines

Candidate number BOOK TWO. NSW Fellowship Course - SAQ trial paper

Institution Subject number. Demographics Age (yrs) Male (0/1) Race (0/1) Hispanic Non-hispanic AA Asian

Mechanical versus bioprosthetic valve. Intern: Supervisor: VS

Case discussion Acute severe asthma during pregnancy. J.G. van der Hoeven

Severe Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Date written: April 2014 Review date: April 2016 Related documents: Paediatric Sepsis 6

Department of Patient Care Services DEVELOPED BY: Critical Care Committee

Case discussion. 2011/03/05 Speaker: R1 游姿寧 Supervisor: F2 黃婷韵

The new psychoactive substances: Toxicity and management

Acute changes in condition: Caring for a child with myocarditis. Looking at the first 48 hours of admission

State of Florida Systemic Supportive Care Guidelines. Michael D. Weiss, M.D. Associate Professor of Pediatrics Division of Neonatology

Case scenario V AV ECMO. Dr Pranay Oza

When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen

CASE PRESENTATION VV ECMO

PEEP recruitment maneuver

NEONATAL HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE) & COOLING THERAPY

ARDS: an update 6 th March A. Hakeem Al Hashim, MD, FRCP SQUH

Teenage Dextromethorphan Abuse: A Rising Trend

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

A Case of Pneumatosis Cystoides Intestinalis Mimicking Intestinal Perforation

TOBY. Daily log. Data Collection Booklet. This form should be completed from the time the baby is randomised until 80 hours after randomisation

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

Epilepsy CASE 1 Localization Differential Diagnosis

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial

UPDATE IN HOSPITAL MEDICINE

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

CSIM/ACP Annual Meeting Banff AB October Scott McKee MD MPH FACP

Rhonda Dixon, DVM Section Head, Emergency and Critical Care Sugar Land Veterinary Specialty and Emergency

Addendum/database Part 1 demographics

Vasopressors in septic shock

CORE CLINICAL DATASET

Transcription:

My Special Cytosorb Case Fabio Silvio TACCONE Dpt of Intensive Care Hôpital Erasme ULB Brussels (BE)

Conflicts of Interest

Clinical Case - 1! 27 yo woman, 45 Kgs (Belgian Vietnam origin)! Blank medical history! Admitted to the ED of another hospital in Brussels because of intoxication! Disco with some friends (Sunday evening)! Found on the floor! Agitated and obtunded! Rigor! Tachycardia! Hypertension (190/100 mmhg)! Hyperthermia (41.6 C)

Clinical Case - 2! Intubated on site! Suspected drug: ECTASY! Unknown dose! Unknown association with other drugs! No other people were intoxicated! Concomitant alcohol intake! First episode according to her friends

! On ED admission:! Sedated and paralyzed! Dilated pupils Clinical Case - 3! HR 130 bpm BP 75/35 mmhg BT 41.8 C! No signs of cyanosis or hypoperfusion! FAST echo = negative! Echo-cardio: LVEF 50%

Chest X-Ray Clinical Case - 4

ECG on ED Admission Clinical Case - 5

! Initial Blood Sample: Clinical Case - 6! ph 7.28 PaCO 2 32 mmhg PaO 2 182 mmhg (FiO 2 100%)! Lactate 3.0 meq/l, sbe -10.9 meq/l, methb 1.1%! WBC: 8,000/mm 3 ; Hb: 13.1 g/dl; PLT: 317,000/mm 3! aptt: 19 secs; INR 0.98; Fibrinogen: 215 mg/dl! Na + : 139 meq/l; K + : 4.9 meq/l; Alb 4.8 g/l;! Urea: 29 mg/dl; Creat 1.6 mg/dl, CK 220 IU/L! Glucose 55 mg/dl, CRP 4.9 mg/l! Ethanol: <0.1 g/l

Clinical Case - 7! Evolution:! Severe shock start Noradrenaline (NA) / Lactate 8.5 meq/l! Diffuse bleeding in the throat, on puncture sites and bladder probe rectal bleeding! PaO 2 112 mmhg (FiO 2 100%)! WBC: 2,000/mm 3 ; Hb: 11.1 g/dl; PLT: 47,000/mm 3! aptt: 85 secs; INR 8.8; Fibrinogen: 45 mg/dl! K + : 5.9 meq/l; Creat 2.1 mg/dl, CK 3220 IU/L! Glucose 15 mg/dl; ALT/AST >200 IU/L; NH4 + 113 µg/dl

! Initial Therapy:! Fluids: 6000 ml (crystalloids)! Noradrenaline: 0.4 µg/kg.min! IV Glucose Clinical Case - 8! Fresh Frozen Plasma: 600 ml! Prothrombin complex concentrates: 400 ml! Tranexamic Acid: 2g! Fibrinogen: 2g! Midazolam: 8 mg/h! Morphine: 5 mg/h

Clinical Case - 9! DIAGNOSIS:! Hepatic Failure < MDMA! Distributive shock! Hypoglycemia! AKI < Rhabdomyolysis! ARDS < inhalation

Clinical Case - 10

Clinical Case - 11! Toxicology:! Methamphetamine: +! Paracetamol: -! Benzodiazepines: -! Cannabis: -! Opiates: -! Antidepressants: -! Barbiturates: -! Cocaine: -! Methadone: -! Phencyclidine: -

Clinical Case - 12! MDMA Toxicity Catecholamine release 5-HT release! CNS (Euphoria Hallucinations - Dizziness Seizures - Bleeding)! Cardiovascular (Tachycardia Hypertension Arrhythmias)! Gastrointestinal! Hyponatremia (ADH sweating)! Serotonin syndrome (hyperthermia, autonomic instability, and altered muscle tone and/or rigidity)! AKI (interstitial nephritis, myoglobinuria)! CIVD (microvascular)! Hepatitis (centrolobular necrosis microvascular steatosis)

Clinical Case - 12! MDMA Toxicity Catecholamine release 5-HT release! CNS! Cardiovascular! Gastrointestinal! Hyponatremia! Serotonin syndrome! AKI! CIVD! Hepatitis

Clinical Case - 13! Therapy:! Supportive! B1 (1500mg)! Protective lung ventilation! Gastrointestinal decontamination (activated charcoal)! Cooling measures! 5-HT antagonists??

Clinical Case - 13! Therapy:! Supportive! B1 (1500mg)! Protective lung ventilation! Gastrointestinal decontamination (activated charcoal)! Cooling measures! 5-HT antagonists??

Clinical Case - 14! Clinical status:! HR 125 bpm BP 100-45 mmhg BT 39.7 C! ph 7.15 PaCO 2 41 mmhg PaO 2 61 mmhg Lactate 8.9 meq/l! 290 T V PEEP 12 cmh 2 0 FiO 2 80% - ΔP 18cmH 2 0! NA 1.3 µg/kg.min! Capillary leakage +++! Hb 10.8 g/dl; Alb 29 g/l; CK 42000 IU/L! Start Amoxi-clav 2g q8h! Start CRRT

Clinical Case - 15 Chest X-Ray VV-ECMO

Idiopathic Drug-induced (Chemotherapy) Retinoic acid syndrome Ovarian hyperstimulation syndrome Hemophagocytic lymphohistiocytosis Hemorrhagic fever Snakebite Sepsis (OPSI) Autoimmune Kawasaki disease Antiphospholipid syndrome Sjögren syndrome Systemic sclerosis Polymyositis Clinical Case - 16

Clinical Case - 17 Colloids IV Vasopressin Hydrocortisone IV β 2 -agonists IVIG Methylene Blue

Clinical Case - 17 Colloids IV Vasopressin Hydrocortisone IV β 2 -agonists IVIG Methylene Blue (2mg/kg)

Clinical Case - 18

Clinical Case - 19 SpO 2 75%

Clinical Case - 20! Clinical status:! HR 135 bpm BP 95-48 mmhg BT 38.5 C (CRRT)! ph 7.23 PaCO 2 41 mmhg PaO 2 54 mmhg SpO2 72%! Lactate 6.9 meq/l! 290 T V PEEP 12 cmh 2 0 FiO 2 100% - ΔP 18cmH 2 0! NA 1.1 µg/kg.min! MetHb 21%

Clinical Case - 21! Methaemoglobinemia - CAUSES: - 30-50% - 50-70% - > 70%

Clinical Case - 22! Methaemoglobinemia - THERAPY:! Remove etiology! Methylene Blue!!!! Vitamine C! Hyperbaric Oxygen! Hemodialysis / Plasmapheresis! Cimetidine (DAPSONE)! NAC

Clinical Case - 23

Clinical Case - 24 PATENT BLUE:! Used in used in lymphangiography and sentinel node biopsy as a dye to color lymph vessels (1-2 mg)! Skin sensitivity, rash, itching, nausea! Urticaria, Hypotension, Bronchospasm! Inhibitory effects on mitochondrial respiration of human cells! Highly protein-bound (Albumin)! Excreted in the urines within 24-48 hours but also into the bile

Clinical Case - 25

NA (mg/kg.min) 1.1 0.9 0.8 Clinical Case - 26

Clinical Case 27

Clinical Case 28 NA (mg/kg.min) 1.1 0.9 0.8 0.7 0.6 0.5

Clinical Case 29 NA (mg/kg.min) 1.1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.1

Clinical Case 30! Weaned from ECMO on day 5! VAP and ICU-AW! Tracheostomy on day 19! Weaned from MV on day 26! Discharged from ICU on day 30! Weaned from tracheostomy on day 41! Discharged rehabilitation on day 56! Back home on day 75

Conclusions! Severe intoxication to MDMA with MOF! Iatrogenic intoxication to Patent Blue! Cytosorb use was associated with reduced MetHb and Lactate levels and improved hemodynamics! Potential role for Cytosorb in drug intoxication

THANKS